Jan 16, 2024, 11:37
Jayastu Senapati: Check out our SOHO State of the Art Review on Acute Lymphoblastic Leukemia
Jayastu Senapati, Assistant Professor at the Department of Leukemia at MD Anderson Cancer Center, shared an X post by Hagop Kantarjian’s, Chair of MD Anderson Cancer Center, and added:
“Check out our SOHO State of the Art Review on Acute Lymphoblastic Leukemia.
- Optimizing F/L use of InO and Blina across B-ALL
- Pona-Blina chemo free RX in Ph+ B-ALL
- Reducing NRM in older ALL
- Nel-PegAsp-Ven in F/L T-ALL
- Consolidative CART in HR and RR B-ALL.”
Quoting Hagop Kantarjian’s post:
“State of the art and next questions: ALL
1. F/L InO/Blina +Chemo: deep and durable resp in B-ALL.
2. Reduction of chemo is prudent in older patients with B-ALL while optimizing InO/Blina use
3. Chemo free Pona+ Blina Rx in Ph+ B-ALL leads to long-term OS.”
Proceed to the article.
Source: Jayastu Senapati/X and Hagop Kantarjian/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 22, 2024, 10:42
Nov 22, 2024, 10:19
Nov 22, 2024, 09:56
Nov 22, 2024, 08:13
Nov 21, 2024, 21:47
Nov 21, 2024, 21:40
Nov 21, 2024, 21:36